DE19715504C2 - PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen - Google Patents

PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen

Info

Publication number
DE19715504C2
DE19715504C2 DE19715504A DE19715504A DE19715504C2 DE 19715504 C2 DE19715504 C2 DE 19715504C2 DE 19715504 A DE19715504 A DE 19715504A DE 19715504 A DE19715504 A DE 19715504A DE 19715504 C2 DE19715504 C2 DE 19715504C2
Authority
DE
Germany
Prior art keywords
peg
membrane
hirudin
pmma
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE19715504A
Other languages
German (de)
English (en)
Other versions
DE19715504A1 (de
Inventor
Elke Bucha
Goetz Nowak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Original Assignee
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19715504A priority Critical patent/DE19715504C2/de
Application filed by Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV filed Critical Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Priority to AT98922710T priority patent/ATE380202T1/de
Priority to EP98922710A priority patent/EP0975680B1/de
Priority to CA2287469A priority patent/CA2287469C/en
Priority to JP54349698A priority patent/JP4495258B2/ja
Priority to EP07122292A priority patent/EP1921094A3/de
Priority to DE59814134T priority patent/DE59814134D1/de
Priority to AU75254/98A priority patent/AU7525498A/en
Priority to ES98922710T priority patent/ES2297886T3/es
Priority to PCT/EP1998/002183 priority patent/WO1998046648A1/de
Publication of DE19715504A1 publication Critical patent/DE19715504A1/de
Priority to US09/417,534 priority patent/US6929955B2/en
Application granted granted Critical
Publication of DE19715504C2 publication Critical patent/DE19715504C2/de
Priority to US11/170,666 priority patent/US7494824B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0081—After-treatment of organic or inorganic membranes
    • B01D67/0093—Chemical modification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/14—Dynamic membranes
    • B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
    • B01D69/1411—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes containing dispersed material in a continuous matrix
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/40—Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
    • B01D71/401—Polymers based on the polymerisation of acrylic acid, e.g. polyacrylate
    • B01D71/4011—Polymethylmethacrylate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19715504A 1997-04-14 1997-04-14 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen Expired - Fee Related DE19715504C2 (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DE19715504A DE19715504C2 (de) 1997-04-14 1997-04-14 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen
ES98922710T ES2297886T3 (es) 1997-04-14 1998-04-14 Sistema de interaccion para la presentacion y retirada de sustancias.
CA2287469A CA2287469C (en) 1997-04-14 1998-04-14 Interactive system for presenting and eliminating substances
JP54349698A JP4495258B2 (ja) 1997-04-14 1998-04-14 物質の供給および除去のための相互作用システム
EP07122292A EP1921094A3 (de) 1997-04-14 1998-04-14 Interaktionssystem zur Präsentation und Entfernung von Substanzen
DE59814134T DE59814134D1 (de) 1997-04-14 1998-04-14 Interaktionssystem zur präsentation und entfernung von substanzen
AT98922710T ATE380202T1 (de) 1997-04-14 1998-04-14 Interaktionssystem zur präsentation und entfernung von substanzen
EP98922710A EP0975680B1 (de) 1997-04-14 1998-04-14 Interaktionssystem zur präsentation und entfernung von substanzen
PCT/EP1998/002183 WO1998046648A1 (de) 1997-04-14 1998-04-14 Interaktionssystem zur präsentation und entfernung von substanzen
AU75254/98A AU7525498A (en) 1997-04-14 1998-04-14 Interactive system for substance presentation and elimination
US09/417,534 US6929955B2 (en) 1997-04-14 1999-10-14 Interactive system for presenting and eliminating substances
US11/170,666 US7494824B2 (en) 1997-04-14 2005-06-29 Interactive system for presenting and eliminating substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19715504A DE19715504C2 (de) 1997-04-14 1997-04-14 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen

Publications (2)

Publication Number Publication Date
DE19715504A1 DE19715504A1 (de) 1998-10-15
DE19715504C2 true DE19715504C2 (de) 2000-10-26

Family

ID=7826448

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19715504A Expired - Fee Related DE19715504C2 (de) 1997-04-14 1997-04-14 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen
DE59814134T Expired - Lifetime DE59814134D1 (de) 1997-04-14 1998-04-14 Interaktionssystem zur präsentation und entfernung von substanzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59814134T Expired - Lifetime DE59814134D1 (de) 1997-04-14 1998-04-14 Interaktionssystem zur präsentation und entfernung von substanzen

Country Status (9)

Country Link
US (2) US6929955B2 (cg-RX-API-DMAC7.html)
EP (2) EP0975680B1 (cg-RX-API-DMAC7.html)
JP (1) JP4495258B2 (cg-RX-API-DMAC7.html)
AT (1) ATE380202T1 (cg-RX-API-DMAC7.html)
AU (1) AU7525498A (cg-RX-API-DMAC7.html)
CA (1) CA2287469C (cg-RX-API-DMAC7.html)
DE (2) DE19715504C2 (cg-RX-API-DMAC7.html)
ES (1) ES2297886T3 (cg-RX-API-DMAC7.html)
WO (1) WO1998046648A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19845286A1 (de) * 1998-10-01 2000-04-27 Udo Dunzendorfer Beschichtete Trägermaterialien für Blut-, Plasma- oder Gewebewäsche und mit diesen Trägermaterialien ausgerüstete Säulen
DE19909584A1 (de) * 1999-03-04 2000-09-14 Haemosys Gmbh Trennverfahren
DE19915862A1 (de) * 1999-04-08 2000-10-12 Max Planck Gesellschaft Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie
DE19918569A1 (de) * 1999-04-23 2000-12-07 Haemosys Gmbh Verfahren zur Diagnose von Krankheiten, pathologischen Zuständen und pathophysiologischen sowie physiologischen Messgrößen
DE19955341A1 (de) * 1999-11-17 2001-08-02 Haemosys Gmbh Blutkompatible Polymeroberflächen
EP1265639A1 (en) * 2000-03-20 2002-12-18 Knoll GmbH The use of anticoagulant agents in the extracorporeal treatment of blood
KR100345323B1 (ko) * 2000-04-24 2002-07-24 학교법인 포항공과대학교 나노 자성체 입자들을 포함하는 복합체
DE10162521A1 (de) * 2001-12-19 2003-07-17 Goetz Nowak Verwendung von molekulargewichtserweiterten Substanzen in der Tumortherapie
EP1443058A1 (en) 2003-01-29 2004-08-04 Firmenich Sa Polymeric particles and fragrance delivery systems
DE10330900B4 (de) † 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
EG23584A (en) * 2003-11-11 2006-09-11 Ali Mokhtar Al-Hossary Amr Elimination of myoglobin from blood using an i v filter
US9561309B2 (en) 2004-05-27 2017-02-07 Advanced Cardiovascular Systems, Inc. Antifouling heparin coatings
DE102005001162A1 (de) * 2005-01-10 2006-07-20 Haemosys Gmbh Adsorptionssystem zur Entfernung von Viren und viralen Bestandteilen aus Flüssigkeiten, insbesondere aus Blut und Blutplasma
RU2453318C2 (ru) 2005-11-14 2012-06-20 Валоризасьон-Решерш, Лимитед Партнершип Фармацевтические композиции, включающие полимерные связующие вещества с негидролизуемыми ковалентными связями, и применение указанных композиций для лечения глютеновой болезни
DE102007033787A1 (de) 2007-07-09 2009-01-15 Aesculap Ag Gefäßprothese mit reduzierter Thrombogenität
DE102008000220A1 (de) * 2008-02-01 2009-08-13 ASCALON Gesellschaft für Innovation in der Medizintechnik m.b.H. Hohlfaser-Separationsmembranen und Verfahren zu ihrer Herstellung
EP2316931B1 (de) 2009-10-30 2016-12-28 Senova Gesellschaft für Biowissenschaft und Technik mbH Polymergekoppelte Peptidasen
EP2620162A1 (de) 2012-01-27 2013-07-31 Life Science Inkubator Enzym-Polymer-Konjugat zur Endotoxin-Detoxifikation
WO2014036608A1 (en) * 2012-09-06 2014-03-13 Adelaide Research & Innovation Pty Ltd Methods and products for preventing and/or treating metastatic cancer

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1603393A (cg-RX-API-DMAC7.html) * 1967-12-27 1971-04-13
JPS4867382A (cg-RX-API-DMAC7.html) * 1971-12-06 1973-09-14
GB1484564A (en) * 1974-07-24 1977-09-01 Koch Light Labor Ltd Stable support material for enzyme insolubilisation
FR2321520A1 (fr) * 1975-08-22 1977-03-18 Rhone Poulenc Ind Latex de polymeres possedant des groupes-cn
DE2552510C3 (de) * 1975-11-22 1981-02-19 Behringwerke Ag, 3550 Marburg Biologisch aktive Verbindungen und Verfahren zu ihrer Herstellung
DE2712344C2 (de) 1977-03-21 1982-09-23 Hans Dr. 4803 Steinhagen Bünemann Löslicher Komplexbildner für die affinitätsspezifische Trennung von Nukleinsäuren
JPS57170263A (en) * 1981-04-14 1982-10-20 Kuraray Co Absorber for blood protein
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
JPH01310668A (ja) 1988-06-09 1989-12-14 Nikkiso Co Ltd 中空糸型血液浄化装置
CA1335142C (en) 1989-07-18 1995-04-04 Leon Edward St-Pierre Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
CA2040996A1 (en) * 1990-05-02 1991-11-03 Robert L. Albright Composition and method for controlling cholesterol
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
SE467309B (sv) * 1990-10-22 1992-06-29 Berol Nobel Ab Hydrofiliserad fast yta, foerfarande foer dess framstaellning samt medel daerfoer
WO1992007882A1 (en) * 1990-10-26 1992-05-14 Genta Incorporated Non-aromatic organic polymeric reagents for solid phase synthesis of oligomers
JPH06256394A (ja) * 1991-08-13 1994-09-13 Kirin Amgen Delaware Inc 修飾インターロイキン6
DE4203965A1 (de) 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren
US5578442A (en) * 1992-03-23 1996-11-26 Vivorx, Inc. Graft copolymers of polycationic species and water-soluble polymers, and use therefor
DE4322884A1 (de) 1992-10-09 1994-04-14 Bayer Ag Biologisch aktive Polymere
US5414075A (en) * 1992-11-06 1995-05-09 Bsi Corporation Restrained multifunctional reagent for surface modification
WO1994025503A1 (en) * 1993-04-27 1994-11-10 Cytotherapeutics, Inc. Membrane formed by an acrylonitrile-based polymer
FR2724461B1 (fr) 1994-09-09 1996-12-20 Prolabo Sa Microsphere de latex biotinylee, procede de preparation d'une telle microsphere et utilisation en tant qu'agent de detection biologique
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
DE19625642A1 (de) 1996-06-26 1998-01-08 Max Planck Gesellschaft Verfahren zur Herstellung einer Antidotausgangssubstanz für natürliche und synthetische Thrombininhibitoren

Also Published As

Publication number Publication date
CA2287469A1 (en) 1998-10-22
JP2001527539A (ja) 2001-12-25
ES2297886T3 (es) 2008-05-01
US7494824B2 (en) 2009-02-24
DE59814134D1 (de) 2008-01-17
EP0975680B1 (de) 2007-12-05
JP4495258B2 (ja) 2010-06-30
AU7525498A (en) 1998-11-11
US20020028201A1 (en) 2002-03-07
US20050239131A1 (en) 2005-10-27
EP0975680A1 (de) 2000-02-02
CA2287469C (en) 2010-02-09
WO1998046648A1 (de) 1998-10-22
ATE380202T1 (de) 2007-12-15
DE19715504A1 (de) 1998-10-15
EP1921094A2 (de) 2008-05-14
EP1921094A3 (de) 2009-06-24
US6929955B2 (en) 2005-08-16

Similar Documents

Publication Publication Date Title
DE19715504A1 (de) PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen
Chenoweth et al. Anaphylatoxin formation during hemodialysis: Comparison of new and re-used dialyzers
Makita et al. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
DE60111688T2 (de) Hämostatische lösliche zellulosefasern enthaltend ein koagulierendes protein zur behandlung von wunden und verfahren zu deren herstellung
DE69333286T2 (de) Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren
DE69929986T2 (de) Verfahren zur entfernung von hiv und anderen viren aus blut
EP1852136A1 (en) Use of a dialysis membrane for preparing a haemodialysis unit for reducing blood free light chain concentration
DE69827229T2 (de) Verwendung eines neutralen oder kationischen Polymers, das zur Verhinderung der Aktivierung der Blut-oder Plasmakontaktphase in Berührung mit einer teildurchlässigen Membran
EP0742022A4 (fr) Hyrogel biocompatible
DD283933A5 (de) Hirudin-beschichtete biocompatible substanz
DE60025698T2 (de) Neue dialysemethode
DE69624914T2 (de) Vorrichtung und verfahren für die biospezifische entfernung von heparin
DE112005001901T5 (de) Einfangen und entfernen von Biomolekülen aus Körperflüssigkeiten unter Verwendung von partiellen molekularen Abdrücken
DE2812174A1 (de) Die blutgerinnung nicht foerdernde, biologisch vertraegliche gegenstaende
DE2725608A1 (de) Verfahren und vorrichtung zum kontinuierlichen entfernen von blutsubstanzen in einem extrakorporalen kreislauf
DE69734862T2 (de) Apparat zur Behandlung des Blutes durch extrakorporalen Blutkreislauf, sowie Verfahren zu seiner Herstellung
DE69734511T2 (de) Antigene modulation von zellen
Inagaki et al. Adsorption of nafamostat mesilate by hemodialysis membranes
Sirolli et al. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis
Sauer et al. Modulation of cytotoxicity of cytostatic drugs by hemodialysis in vitro and in vivo
DE2732437B2 (de) Wasserunlösliches Haptoglobinpräparat und Verfahren zu seiner Herstellung
DE19955341A1 (de) Blutkompatible Polymeroberflächen
DE4428056A1 (de) Verwendung von Mikropartikelpräparationen zur Eliminierung gelöster, nicht nierengängiger Substanzen aus dem Blut
DE3406562A1 (de) Membran fuer die inaktivierung von heparin in blut und blutfraktionen, verfahren zu ihrer herstellung, ihre verwendung und verfahren zur inaktivierung von heparin in blut und blutfraktionen
DE2532883C2 (de) Verfahren und Vorrichtung zur selektiven Gewinnung eines Reaktionspartners einer Immunreaktion aus dem strömenden Blut von lebenden Organismen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20131101